Apexigen Inc Stock Ownership - Who owns Apexigen?

Insider buying vs selling

Have Apexigen Inc insiders been buying or selling?
William E. DukeChief Financial Officer2023-05-2317,261$0.40
Amy WongSVP Finance and Operations2023-05-2312,234$0.40
Francis Willard SarenaPresident and COO2023-05-2320,748$0.40
Amy WongSVP Finance and Operations2022-12-152,851$1.06
William E. DukeChief Financial Officer2022-12-154,503$1.06
Xiaodong YangChief Executive Officer2022-12-157,001$1.06
Frank J. HsuChief Medical Officer2022-12-154,323$1.06
Francis Willard SarenaChief Operating Officer2022-12-156,916$1.06

1 of 1

APGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGN insiders and whales buy or sell their stock.

APGN Shareholders

What type of owners hold Apexigen Inc stock?
Decheng Capital Management Iii Cayman LLC7.68%1,894,551$1.02MInstitution
Brookline Capital Holdings LLC6.60%1,627,000$878.58kInsider
Xiaodong Yang2.15%531,391$286.95kInsider
Yu Fan 11.63%401,757$216.95kInstitution
Vanguard Group Inc1.04%256,935$138.74kInstitution
Glazer Capital LLC0.91%225,000$121.50kInsider
Blackrock Inc0.87%213,833$115.47kInstitution
Geode Capital Management LLC0.72%178,760$96.53kInstitution
Francis Willard Sarena0.66%162,336$87.66kInsider
William E. Duke0.64%158,921$85.82kInsider

1 of 3

APGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGN13.65%12.03%Net SellingNet Selling
FNCH19.84%39.65%Net Selling
INDP6.90%83.39%Net Buying
JAGX1.92%48.80%Net Buying

Apexigen Stock Ownership FAQ

Who owns Apexigen?

Apexigen (NASDAQ: APGN) is owned by 13.65% institutional shareholders, 12.03% Apexigen insiders, and 74.32% retail investors. Brookline Capital Holdings LLC is the largest individual Apexigen shareholder, owning 1.63M shares representing 6.60% of the company. Brookline Capital Holdings LLC's Apexigen shares are currently valued at $878.58k.

If you're new to stock investing, here's how to buy Apexigen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.